Searchable abstracts of presentations at key conferences in endocrinology

ea0029p163 | Bone & Osteoporosis | ICEECE2012

Effect of alendronate on bone mineral density in primary hyperparathyroidism

Szymczak J. , Bohdanowicz-Pawlak A. , Jakubowska J.

Background: Bisphosphonates are capable of suppressing parathormone (PTH)-mediated bone resorption and can be used as an adjunct treatment in acute hypercalcemia. We investigated the effects of oral alendronate on bone mineral density (BMD) and biochemical markers of calcium and bone metabolism in patients with primary hyperparathyroidism (PHPT).Methods: Twenty-six patients aged 58.5±13.9 years with confirmed PHPT were treated with alendronate (70 m...

ea0029p331 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Vitamin D serum levels and cardiovascular risk factors in postmenopausal women

Bohdanowicz-Pawlak A. , Milewicz A. , Jedrzejuk D. , Szymczak J. , Arkowska A.

Results of several clinical studies have suggested that there is an excess risk of cardiovascular disease in persons with vitamin D deficiency.We examined association between serum levels of vitamin D - 25(OH)D and select cardiovascular risk factors in 254 postmenopausal women at a mean age of 55.38±205 years.Vitamin D levels, lipoproteins, TNF-α, Interleukin 6, adiponectin, insulin (using RIA methods) and glucose were as...